CH618432A5 - Process for the preparation of a 2,4-diamino-5-benzylpyrimidine intended for the production of tablets - Google Patents

Process for the preparation of a 2,4-diamino-5-benzylpyrimidine intended for the production of tablets Download PDF

Info

Publication number
CH618432A5
CH618432A5 CH174775A CH174775A CH618432A5 CH 618432 A5 CH618432 A5 CH 618432A5 CH 174775 A CH174775 A CH 174775A CH 174775 A CH174775 A CH 174775A CH 618432 A5 CH618432 A5 CH 618432A5
Authority
CH
Switzerland
Prior art keywords
tablet
minutes
tablets
weight
trimethoprim
Prior art date
Application number
CH174775A
Other languages
German (de)
English (en)
Inventor
Allan John Torode
David Harden
John Spence
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH618432(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH618432A5 publication Critical patent/CH618432A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
CH174775A 1974-02-14 1975-02-13 Process for the preparation of a 2,4-diamino-5-benzylpyrimidine intended for the production of tablets CH618432A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (1)

Publication Number Publication Date
CH618432A5 true CH618432A5 (en) 1980-07-31

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
CH174775A CH618432A5 (en) 1974-02-14 1975-02-13 Process for the preparation of a 2,4-diamino-5-benzylpyrimidine intended for the production of tablets

Country Status (32)

Country Link
JP (1) JPS5545043B2 (nl)
AT (1) AT344915B (nl)
AU (1) AU468465B2 (nl)
BE (1) BE825496A (nl)
CA (1) CA980688A (nl)
CH (1) CH618432A5 (nl)
CS (1) CS220306B2 (nl)
CY (1) CY1052A (nl)
DD (1) DD118228A5 (nl)
DE (1) DE2506099C2 (nl)
DK (1) DK143247C (nl)
DO (1) DOP1979002763A (nl)
ES (1) ES434688A1 (nl)
FI (1) FI62219C (nl)
FR (1) FR2260993B1 (nl)
GB (1) GB1499672A (nl)
GT (1) GT197960431A (nl)
HK (1) HK23980A (nl)
HU (1) HU171536B (nl)
IE (1) IE40599B1 (nl)
IL (1) IL46629A (nl)
IN (1) IN141019B (nl)
KE (1) KE3038A (nl)
LU (1) LU71835A1 (nl)
MC (1) MC1053A1 (nl)
MY (1) MY8100054A (nl)
NL (1) NL157501C (nl)
NO (1) NO146043C (nl)
PH (1) PH14575A (nl)
SE (1) SE427898B (nl)
ZA (1) ZA75930B (nl)
ZM (1) ZM1875A1 (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
DK143247B (da) 1981-08-03
NL157501C (nl) 1981-07-16
ZA75930B (en) 1976-01-28
NL157501B (nl) 1978-08-15
ATA108475A (de) 1977-12-15
KE3038A (en) 1980-04-25
NO146043B (no) 1982-04-13
ZM1875A1 (en) 1975-12-22
FR2260993B1 (nl) 1978-06-30
CY1052A (en) 1980-08-01
AU7817075A (en) 1976-01-15
HK23980A (en) 1980-05-09
JPS5545043B2 (nl) 1980-11-15
NO146043C (no) 1982-08-04
FI750398A (nl) 1975-08-15
AU468465B2 (en) 1976-01-15
DE2506099C2 (de) 1983-11-03
AT344915B (de) 1978-08-25
DE2506099A1 (de) 1975-08-21
SE427898B (sv) 1983-05-24
MY8100054A (en) 1981-12-31
SE7501595L (nl) 1975-08-15
NL7501680A (nl) 1975-08-18
ES434688A1 (es) 1977-04-01
DK52875A (nl) 1975-10-06
FR2260993A1 (nl) 1975-09-12
DD118228A5 (nl) 1976-02-20
NO750467L (nl) 1975-08-15
CS220306B2 (en) 1983-03-25
DOP1979002763A (es) 1987-06-18
GB1499672A (en) 1978-02-01
DK143247C (da) 1981-11-30
GT197960431A (es) 1981-05-05
IN141019B (nl) 1977-01-08
CA980688A (en) 1975-12-30
JPS50116627A (nl) 1975-09-12
IE40599B1 (en) 1979-07-04
IE40599L (en) 1975-08-14
PH14575A (en) 1981-09-24
FI62219C (fi) 1982-12-10
MC1053A1 (fr) 1976-02-20
IL46629A (en) 1977-07-31
HU171536B (hu) 1978-01-28
FI62219B (fi) 1982-08-31
LU71835A1 (nl) 1975-06-24
BE825496A (fr) 1975-05-29
IL46629A0 (en) 1975-05-22

Similar Documents

Publication Publication Date Title
DE3688674T2 (de) Hydroxypropylcelluloseether enthaltende Mittel mit verzögerter Wirkstoffabgabe.
DE69400356T2 (de) Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
DE68916983T2 (de) Verfahren zur Herstellung eines pharmazeutischen Granulats.
DE3780056T2 (de) Verfahren zur herstellung von arzneimittelformulierungen mit gesteuerter und verlaengerter wirkung in einzeldosisform mit einheitlichen und vergleichbaren bioverfuegbarkeitscharakteristika.
US4209513A (en) Tablet formulation
DE2400819A1 (de) Verfahren zur herstellung fester zubereitungen von schwerloeslichen arzneimittelwirkstoffen in feinster verteilung
DE60224056T2 (de) Antazide und laxative magnesiumoxid-tablette
CH657046A5 (de) Pharmazeutische zusammensetzungen mit verzoegerter freigabe des wirkstoffes.
DE2241960C2 (de) Freifließendes Granulat zur Tablettenherstellung
DE2200778B2 (de) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
DE69108007T2 (de) Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung.
EP0275468A1 (de) Clodronat-haltige Arzneimittel und Verfahren zur Herstellung derselben
CH618432A5 (en) Process for the preparation of a 2,4-diamino-5-benzylpyrimidine intended for the production of tablets
EP0146863A2 (de) Orale retardierte Acetylsalicylsäureformulierungen
EP0414115B1 (de) Hilfsmittelfreie Riboflavingranulate
EP2299982A1 (de) Direkt verpressbare und schnell zerfallende tablettenmatirx
EP2451446B1 (de) Zusammensetzung für die tablettenherstellung und verfahren zu deren herstellung
DE60005469T2 (de) Arzneizusammensetzung enthaltend Ascorbinsäure und Pektin
DE2050701C3 (de) Verwendung eines pulverförmigen Celluloseäthers als Hilfsstoff zur Herstellung von leicht zerfallbaren festen Arzneiformen
EP2451447B1 (de) Wasserarmes tablettierhilfsmittel und verfahren zu seiner herstellung
DE3419131A1 (de) Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
DE1931910A1 (de) Verfahren zur Herstellung von festen Arzneizubereitungen mit gesteuerter Resorption
DE68907609T2 (de) Arzneimittelzusammensetzung.
DE2605656A1 (de) Pharmazeutische zubereitungen in tablettenform

Legal Events

Date Code Title Description
PL Patent ceased